Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Mitsuo Honda"'
Autor:
Shihoko Komine-Aizawa, Satoru Mizuno, Kazuhiro Matsuo, Takahiro Namiki, Satoshi Hayakawa, Mitsuo Honda
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1260 (2021)
The incidence of infections with nontuberculous mycobacteria (NTM) has been increasing worldwide. The emergence of multidrug-resistant NTM is a serious clinical concern, and a vaccine for NTM has not yet been developed. We previously developed a new
Externí odkaz:
https://doaj.org/article/077b4100a78f471f82f3c994dbe021c5
Autor:
Shihoko Komine-Aizawa, Satoru Mizuno, Akira Kawano, Satoshi Hayakawa, Kazuhiro Matsuo, Mitsuo Honda
Publikováno v:
International Journal of Molecular Sciences. 24:966
Mycobacterium tuberculosis (Mtb) infection remains a major health problem worldwide. Although the Bacillus Calmette-Guérin (BCG) vaccine is the most widely used vaccination for preventing tuberculosis (TB), its efficacy is limited. We previously dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b830f9a604ebd8e70dafd10602b7f0ba
https://doi.org/10.3390/ijms24020966
https://doi.org/10.3390/ijms24020966
Autor:
Satoshi Hayakawa, Jiansheng Jiang, Kazuhiro Matsuo, David H. Margulies, Mitsuo Honda, Lisa F. Boyd, Shihoko Komine-Aizawa, Satoru Mizuno
Publikováno v:
European Journal of Immunology. 49:1399-1414
Despite efforts to develop effective treatments and vaccines, Mycobacterium tuberculosis (Mtb), particularly pulmonary Mtb, continues to provide major health challenges worldwide. To improve immunization against the persistent health challenge of Mtb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcbb29641fc1153936b6404734cf3ea8
https://doi.org/10.1002/eji.201847988
https://doi.org/10.1002/eji.201847988
Autor:
Mitsuo Honda, Satoshi Hayakawa, Takahiro Namiki, Satoru Mizuno, Kazuhiro Matsuo, Shihoko Komine-Aizawa
Publikováno v:
Vaccines
Volume 9
Issue 11
Vaccines, Vol 9, Iss 1260, p 1260 (2021)
Volume 9
Issue 11
Vaccines, Vol 9, Iss 1260, p 1260 (2021)
The incidence of infections with nontuberculous mycobacteria (NTM) has been increasing worldwide. The emergence of multidrug-resistant NTM is a serious clinical concern, and a vaccine for NTM has not yet been developed. We previously developed a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e115f20f6d022ca84752bad4e7cd8e5b
https://doi.org/10.3390/vaccines9111260
https://doi.org/10.3390/vaccines9111260
Autor:
David H. Margulies, Kazuhiro Matsuo, Shihoko Komine-Aizawa, Lisa F. Boyd, Satoshi Hayakawa, Jiansheng Jiang, Satoru Mizuno, Mitsuo Honda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a681f3f0f5334dace23dcccf138e53ac
https://doi.org/10.1002/eji.201847988/v2/response1
https://doi.org/10.1002/eji.201847988/v2/response1
Autor:
Shihoko, Komine-Aizawa, Jiansheng, Jiang, Satoru, Mizuno, Satoshi, Hayakawa, Kazuhiro, Matsuo, Lisa F, Boyd, David H, Margulies, Mitsuo, Honda
Publikováno v:
Eur J Immunol
Despite efforts to develop effective treatments and vaccines, Mycobacterium tuberculosis (Mtb), particularly pulmonary Mtb, continues to provide major health challenges worldwide. To improve immunization against the persistent health challenge of Mtb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49a471c33850b4471ed6d3a065e12a2b
https://pubmed.ncbi.nlm.nih.gov/31135967
https://pubmed.ncbi.nlm.nih.gov/31135967
Autor:
Yun Ji, Lukas Flatz, Francois Lefebvre, Rafick Pierre Sekaly, Carmen N. Nichols, Luca Gattinoni, Li Pan, Mitsuo Honda, Ahmed N. Hegazy, Slim Fourati, Jean Philippe Goulet, Christopher A. Klebanoff, Mark J. Cameron, Rahul Roychoudhuri, Michel Gilliet, Gary J. Nabel, Nicholas P. Restifo
Publikováno v:
Vaccine. 33:914-923
The generation of CD8(+) T-cell memory is a major aim of vaccination. While distinct subsets of CD8(+) T-cells are generated following immunization that differ in their ability to confer long-term immunity against infection, the transcriptional profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f029bc5a627fd46248169d1c67aa7a6
https://doi.org/10.1016/j.vaccine.2014.10.007
https://doi.org/10.1016/j.vaccine.2014.10.007
Autor:
Kazumasa Fuwa, Mitsuo Honda, Satoshi Hayakawa, Ngan Thi Kim Pham, Shihoko Komine-Aizawa, Kazuhide Takada, Quang Duy Trinh, Hiroshi Ushijima
Publikováno v:
Clinical laboratory. 62(12)
Background High-mobility group box 1 (HMGB1), a DNA-binding protein, has recently been shown to have effects on HIV replication, but the effects are dependent on the cell type and the timing of infection. Using human primary T cells, this study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d9e173cb6015c5f645f19d387540d3
https://pubmed.ncbi.nlm.nih.gov/28164548
https://pubmed.ncbi.nlm.nih.gov/28164548
Autor:
Mitsuo Honda
Publikováno v:
Journal of Nihon University Medical Association. 72:171-174
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::188022641f3d2541c8951192f0452958
https://doi.org/10.4264/numa.72.171
https://doi.org/10.4264/numa.72.171
Autor:
Shigeru Kusagawa, Mitsuo Honda, Naoki Yamamoto, Mari Takizawa, Kosuke Miyauchi, Katsuhiko Kitamura, Jun Komano, Emiko Urano, Satoshi Naganawa, Toshio Murakami
Publikováno v:
AIDS. 25:2209-2216
A humanized neutralizing antibody, KD-247, targets the V3 loop of HIV-1 Env. HIV-1 bearing the GPGR sequence at the V3 loop is potentially susceptible to KD-247. However, not all GPGR-positive HIV-1 isolates are neutralized by KD-247. We examined the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21bec2efdba0c86dcc107a15ea3e5e
https://doi.org/10.1097/qad.0b013e32834bab68
https://doi.org/10.1097/qad.0b013e32834bab68